JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Bermekimab is an investigational antibody that blocks the action of IL-1a, a cytokine thought to drive inflammation associated with chronic skin diseases including atopic dermatitis and hidradenitis suppurativa.